Read by QxMD icon Read

acute myelocytic leukemia management

Xia Yang, Wei Liu, Allie Lyons, Zaiwei Song, Suodi Zhai, Kai Hu
BACKGROUND: The incidence of cytarabine-induced pericarditis is rare. So far, only a few cases have been reported worldwide. DESCRIPTION OF THE CASE: We are reporting a case of a 25-year-old male with acute myeloid leukemia (AML M2a) on chemotherapy who developed acute pericarditis after the administration of a cytarabine-containing regimen. The symptoms gradually improved after symptomatic treatment with steroids and other drugs. CONCLUSIONS: This case demonstrates that, although pericarditis induced by cytarabine is rare, early recognition of this potentially life-threatening complication and appropriate management will usually result in the patient's recovery...
February 2018: European Journal of Clinical Pharmacology
Hideaki Yamakawa, Masahiro Yoshida, Noriyuki Morikawa, Shota Fujimoto, Takeo Ishikawa, Koji Sano, Kaichi Nishiwaki, Masamichi Takagi, Masahiro Hayashi, Kazuyoshi Kuwano, Keisuke Aiba
We herein report the case of a 68-year-old man with a history of allogeneic hematopoietic stem cell transplantation for acute myelocytic leukemia in whom graft-versus-host disease (GVHD) developed in the gastrointestinal tract and liver five months after transplantation. In that same period, chest computed tomography showed infiltration in both upper lungs. We performed bronchoscopy to clarify the GVHD and pulmonary infection. Nocardia nova was identified in the bronchoalveolar lavage fluid, and we diagnosed the patient as having pulmonary nocardiosis...
2014: Internal Medicine
Sergio Parco, Fulvia Vascotto
BACKGROUND: The immature (or reticulated) platelet fraction (IPF) is rich in nucleic acids, especially RNA, and can be used as a predictive factor for platelet recovery in platelet immunomediated consumption or in postchemotherapy myelosuppression. Our aim was to determine if transfusions with IPF-rich solutions, during autologous peripheral blood stem cell transplantation, reduce the occurrence of bleeding and hemorrhagic complications. PATIENTS AND METHODS: Transfusions were administered to 40 children, affected with hematological pathologies, who underwent autologous peripheral hematopoietic progenitor cell transplantation...
2012: OncoTargets and Therapy
Ramez N Eskander, Maryam Tarsa, Kenneth D Herbst, Thomas F Kelly
Leukemia during pregnancy is rare, posing a complex series of questions, including appropriate therapy and maternal counseling. Management of chronic myelocytic leukemia (CML) during pregnancy is limited. Our patient presented at 30 weeks' gestation with anemia, leukocytosis, and a non-productive cough. Polymerase chain reaction performed on a peripheral blood sample confirmed presence of the breakpoint cluster region-Abl1 chromosomal translocation and the diagnosis of CML. Therapy included acute leukocytapheresis, followed by α-interferon and imatinib mesylate...
November 2011: Journal of Obstetrics and Gynaecology Research
M Hoopmann, G Rahimi, I Hartlapp, F Eifinger, Y Garnier, R Bald
This article discusses the management of a pregnancy of a 32-year-old primigravida with acute myelocytic leukemia treated with induction chemotherapy starting in the 20 + 5 week of gestation. Sonographic monitoring showed evidence of fetal ascites and anemia that could be treated with an intrauterine fetal transfusion. After maternal recovery, a caesarean section was performed in the 27 + 5 week of gestation. We delivered a vivid eutrophic female prematurely. The infant showed persisting signs of myelosuppression...
August 2008: Ultraschall in der Medizin
Richard H Scott, Sahar Mansour, Kathryn Pritchard-Jones, Devinder Kumar, Fergus MacSweeney, Nazneen Rahman
Background A 13-year-old girl presented with rectal bleeding and was found to have two colonic carcinomas (stage Dukes' C) and multiple colonic polyps. At the age of 7 years she had widespread hyperpigmented and hypopigmented skin lesions, and had developed medulloblastoma, which was treated with chemotherapy and craniospinal irradiation. At the age of 10 years she had developed acute myelocytic leukemia, M5. She was treated with chemotherapy including sibling bone marrow transplant with busulfan/cyclophosphamide conditioning...
February 2007: Nature Clinical Practice. Oncology
Kathryn E Dusenbery, Ellen E Bellairs, Roger A Potish, Leo B Twiggs, Matthew P Boente
OBJECTIVE: The purpose of the present study is evaluation of the long-term efficacy of sequential abdominopelvic radiotherapy and melphalan in the management of ovarian carcinoma. METHODS: From 1970 to 1976, 94 women with stages I-III epithelial ovarian carcinoma enrolled in a prospective nonrandomized clinical trial were prescribed 20 Gy to the upper abdomen and 50 Gy to the pelvis followed by courses of melphalan (1 mg/kg/course). Primary endpoints were survival, recurrence, and toxicity...
February 2005: Gynecologic Oncology
Gulden Ersoz, Feza Otag, Zayre Erturan, Gonul Aslan, Ali Kaya, Gürol Emekdas, Takashi Sugita
A mini epidemic of Dipodascus capitatus (teleomorph of Geotrichum capitatum) involving three cases is reported. The index case was pulmonary infection and a fulminant course of fungal infection, which resulted in the patient's death with acute myelocytic leukemia. In the other cases, the patients were simultaneously hospitalized, the first in the intensive care unit. In all cases, D. capitatus was identified in different samples (sputum, deep tracheal aspiration, blood, and urine) from each of the patients...
December 2004: Japanese Journal of Infectious Diseases
G Iervese, T Spina, G Mascitelli, P Acquarola, P Orlandi, G Bosco
Oncologic diseases frequently need a central venous catheterization to improve pharmacological administration safety and patient's comfort. We report a case of a woman affected by acute myelocytic leukemia with a bilateral stenosis of the innominate veins, likely of thrombotic nature, diagnosed during central venous catheterization. These events, as that occurred to our patient, are usually caused by hypercoagulability inducted by oncologic diseases, sepsis, antithrombin III deficiency, catheters materials and repeated catheterizations...
July 2002: Minerva Anestesiologica
P S Malhotra, D Danahey, J Sidman
OBJECTIVE: To determine if simultaneous, bilateral lateral rhinotomies for medial maxillectomies would result in central skin or bone loss in pediatric patients with invasive fungal disease. STUDY DESIGN: Retrospective chart review. SETTING: Tertiary care children's hospital. PATIENTS: Three children underwent surgery between April 1996 and June 1998. Ages at treatment ranged from 11 to 14 years. All had bilateral, biopsy-proven invasive fungal disease of the lateral walls of the nose...
November 2001: Laryngoscope
Y Miyazaki, K Kuriyama
Many laboratory methods are used to diagnose acute myelocytic leukemia(AML) including morphological analysis, phenotypic analysis, chromosomal and genetic analysis of leukemic blasts. The FAB classification is widely used for the diagnosis and classification of AML because of its convenience. This classification is mainly based on morphological and cytochemical results which are well established and economical methods. Phenotypic analyses using flow cytometry provides useful information regarding the lineage and maturation status of leukemic cells...
August 2000: Rinsho Byori. the Japanese Journal of Clinical Pathology
CHARACTERISTICS AND PATHOLOGY OF MYELODYSPLASTIC SYNROME: Myelodysplastic syndrome (MDS) is a disease of the blood whose etiology is unclear. There is little that can be done therapeutically, and the prognosis for patients with this disease is poor. The main hematologic finding is anemia, but MDS responds poorly to the various kinds of drugs used to treat anemia, and in the past it was called refractory anemia. Moreover, 25% to 40% of MDS patients develop acute leukemia, so MDS has also been referred to as preleukemia or a preleukemic condition...
1996: Oncologist
Teramura, Mizoguchi
WHAT IS HYPOPLASTIC ANEMIA? Aplastic anemia is a hematological disease characterized by pancytopenia and bone marrow hypoplasia. Acquired cases of aplastic anemia are almost all idiopathic and arise from unknown causes. Other cases of aplastic anemia are secondary and are caused by radiation, chemicals or viruses. PATHOPHYSIOLOGY: Aplastic anemia is manifested as a marked reduction in the number of pluripotent hematopoietic stem cells, but why this occurs is still uncertain. Some of the proposed causes include abnormalities of the hematopoietic stem cells, abnormalities in the hematopoietic microenvironment, and immunologically mediated damage to the hematopoietic stem cells (Figure 1)...
1996: Oncologist
M Rybojad, H Bredoux, M D Vignon-Pennamen, F Prigent, P Morel, E Bourrat
BACKGROUND: Specific cutaneous involvement is frequently observed in congenital leukemia and may be the inaugural sign. Lesions may be non-specific and even regress spontaneously, misleading diagnosis and delaying care. CASE REPORT: A infant in good health had diffuse ecchymotic maculae at birth which totally regressed within 10 days. On day 20, a macular rash and three violet nodules developed. The physical examination found enlarged nodes, liver enlargement and poor general status...
February 1999: Annales de Dermatologie et de Vénéréologie
P Raab, J Kühl, R Krauspe
Adequate treatment protocols provide excellent results in management of lymphoma, leukemia and other malignancies in children. With improved survival rates, therapy related sequaela like osteonecrosis (avascular necrosis of bone, AVN) have become a matter of increasing concern. From 1982 to 1992 121 patients were treated for acute lymphocytic leukemia, acute myelocytic leukemia, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma and Langerhanscell-histiocytosis. All patients were treated with multiagent regimes that included low-dose steroid therapy...
September 1997: Zeitschrift Für Orthopädie und Ihre Grenzgebiete
E Perucca, V Dezerega, R González, A Rodríguez, R Aparicio, V Lois
A clinical case is presented of a 37 year old patient with acute myelocytic leukemia who conceived while in therapy. The pregnancy was controlled in our department in association with the Hematology Department. A cesarean section was performed in the 37th week of gestation, resulting in a healthy newborn. A review of literature is presented, analyzing the association between these two conditions, as well as repercussion on the mother and infant and the recommended obstetric management.
1995: Revista Chilena de Obstetricia y Ginecología
K U Kim, J K Kim, J H Won, D S Hong, H S Park
The decision to operate for abdominal pain in patients with leukopenia can be exceedingly difficult. Surgical exploration may be the only effective way to differentiate acute appendicitis from other causes, but it involves considerable risk of infectious complications due to immunosuppression. Leukemic patients, who presented significant RLQ pain, had been indicated for operation, despite having advanced disease or having had received chemotherapy or steroids. Four adult leukemia patients, complicated by acute appendicitis, were reviewed...
January 1993: Korean Journal of Internal Medicine
L Bergmann, G Heil, K Kolbe, E Lengfelder, E Puzicha, H Martin, J Lohmeyer, P S Mitrou, D Hoelzer
The activation of autologous cytotoxic cells by interleukin-2 (IL-2) may be a promising tool for elimination of minimal residual blast populations in patients with acute myelocytic leukemia (AML) to prolong disease-free survival. Here, we report the results of a phase II study using IL-2 for consolidation therapy in patients with second remission of de novo AML. All patients in 1st relapse of AML received a uniform induction therapy consisting of intermediate high-dose AraC (iHDAraC) 2 x 600 mg/m2 d1-4 and VP-16 100 mg/m2 d1-7...
January 1995: Leukemia & Lymphoma
T P Duffy
No abstract text is available yet for this article.
July 1980: Connecticut Medicine
I Takahashi, M Hara, K Uchida, K Takaoka, S Watanabe, M Lai, K Hamasaki, F Kohi, K Kitajima, I Kimura, T Adachi, S Yorimitsu, M Tokioka, H Sanada
Relapses in nine patients with acute myelocytic leukemia were treated with a combination of aclarubicin (ACR) and cytosine arabinoside (ara-C). ACR, 40 mg/m2/day, was administered daily by intravenous injection from day 1 to day 3 and ara-C, 60-80 mg/m2/day, divided into 2 doses, was given every 12 h by intravenous infusion from day 1 to day 7. Depending on the state of the bone marrow, ACR-ara-C regimen was modified in administration period and repeated after the resting periods of at least 7 days. Complete remission was obtained in 7 of 9 patients (77...
February 1982: Acta Medica Okayama
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"